See Related Pages
- Ask the Allergist About Asthma
- Asthma Diagnosis and Testing
- Asthma Symptoms & Triggers
- Asthma Medication and Treatment
- Asthma Management and Control
- Asthma Patient Assistance
- Asthma Action Plan
- What is Severe Asthma?
- Asthma and Exercise
- Asthma in Babies and Children
- Asthma and Pregnancy
- Vaping and Smoking with Asthma
- Asthma Webinars
- Asthma Dictionary
- Asthma Statistics
What causes asthma?
Severe asthma is asthma that, despite all that you do:
- requires high-dose inhaled corticosteroids plus long-acting beta2-agonists and/or additional controller medication or
- requires oral corticosteroids to prevent it from becoming uncontrolled or remains uncontrolled despite therapy.
People with severe asthma often experience high rates of emergency department visits, hospitalizations and school or work absenteeism. They often find themselves unable to perform simple activities of daily living.
Once considered a single, though complex disease, asthma is now recognized as a syndrome or spectrum of diseases with environmental and genetic factors that cause airway inflammation and bronchospasm – leading to coughing, wheezing and shortness of breath. Severe asthma is one form of the disease.
Each person’s asthma experience is unique to them.
COVID-19 Info Center -->
Asthma is a complex, ever-changing condition that requires constant attention. If your symptoms worsen, then a visit to an asthma specialist (board-certified allergist or pulmonologist) is in order.
How common is severe asthma?
It’s estimated that 5-10 percent of people with asthma have severe asthma. However, the percentage may be higher. Studies show about 50 percent of asthma patients have poorly controlled symptoms despite treatment.
Is there a difference between severe asthma and uncontrolled asthma?
Not all uncontrolled asthma is severe and not all severe asthma is uncontrolled. A person with mild or moderate asthma can have uncontrolled asthma.
Lack of control is defined using Baylor University’s Rules of Two ®. Your asthma is considered uncontrolled if you experience any or all of the following:
- You use your quick relief inhaler each week
- You need oral steroids
- You have asthma symptoms at night
- You have to refill your quick-relief inhaler often
Severe asthma is not always uncontrolled. Severe asthma is asthma that requires a higher level of daily treatment. The measure of severe asthma is based upon:
- How often you need your controller medication
- The frequency and duration of your asthma symptoms
- The impact of asthma on your daily life
There are several asthma assessment tools you can use to determine if your asthma is in control or not:
Rules of Two
Asthma Control Test
Asthma Control Test
for children ages 4 to 11 years and teens 12 and older
Asthma Control & Severity Assessment Tool
How is severe asthma diagnosed?
Severe asthma is diagnosed when your symptoms are not well controlled with your asthma medications. Those medications may include:
- inhaled corticosteroids
- short- and long-acting beta2-agonists (SABA, LABA)
- leukotriene inhibitors such as montelukast
- long-acting muscarinic inhibitors (LAMA).
What are asthma phenotypes?
A phenotype is a collection of characteristics. An asthma specialist will first identify characteristics of your asthma using skin and blood tests, FeNO (fractional exhaled nitric oxide) measurements, sputum analysis and/or bronchoscopy. For some patients, high serum IgE levels and/or high eosinophil counts and high FeNO levels are associated with increased symptoms and asthma flares.
For some patients, high serum IgE levels and/or high eosinophil counts and high FeNO levels are associated with increased symptoms and asthma flares. For others, thickening of airway smooth muscle may be the primary contributor.
Treatments for Each Severe Asthma Phenotype
Researchers have identified four different asthma phenotypes. Each phenotype responds best to its own targeted treatment.
What is Type 2 inflammation?
Recent treatment breakthroughs focus on a certain type of airway inflammation. This is called Type 2 inflammation. Type 2 inflammation is a systemic allergic response involving high levels of immunoglobulin E (IgE) antibodies and white blood cells called eosinophils. It can result in increased likelihood of asthma flares. Approximately 50-70% of asthma patients have Type 2 inflammation.
How can immunotherapy help severe allergic asthma?
If you have allergic asthma, you should consider talking with your doctor about allergen immunotherapy. Immunotherapy can reduce some underlying triggers of asthma such as pollen, mold, house dust mites and pet dander. It may also decrease the severity of your symptoms over time.
It’s important to have a discussion with a board-certified allergist who can evaluate your symptoms and help you determine the best immunotherapy option for you.
What other factors that may play a role in assessing your asthma severity and treatment options?
Other factors that may play a role in assessing asthma severity and treatment options, including:
- Inhaler technique
- Medication adherence
- Allergen avoidance
- Stress management
- Access to treatment
- Cost of treatment
What should I take to my doctor appointments if I’m concerned I might have severe asthma?
It helps to prepare for your doctor’s visits when you’re concerned about your asthma. These tools can help you cover everything you want to communicate with your care provider.
What Tools Can Doctors Use for Asthma Patient Visits
A checklist helps move the office visit along with patients with uncontrolled asthma
Steps to Shared Decision Making
What are the long term effects of inadequate asthma control?
The body’s attempts to correct the damage from inflammation can also lead to airway remodeling. Airway remodeling means that permanent structural and functional changes in the lung occur due to inflammation. For this reason, it is very important to work with your doctor to get the best asthma control that you can.
Additional Severe Asthma Resources
We invite you to take part in the NHLBI-sponsored PrecISE study to examine ways to treat people with severe asthma.
The National Institutes of Health released a focused update to its federal asthma guidelines. The updates are intended to improve asthma care.
If you have moderate or severe asthma, we invite you to participate in a new clinical trial for a potential new medication.
The US FDA has announced a voluntary recall of the Perrigo albuterol inhaler used to treat asthma and other respiratory diseases.
If you’re unable to work due to severe asthma, here is what you need to know on filing a claim for Social Security disability benefits.
News regarding the findings of a study regarding the impact of long-term use of e-cigarettes for those with respiratory diseases, including asthma and COPD.
Download Our Free “Understanding Asthma” Guide
How do I monitor my daily asthma symptoms?
National asthma guidelines suggest using a daily symptom diary such as Allergy & Asthma Network’s AsthmaTracker™ to keep track of symptoms, peak expiratory flow rates (if you or your child use a peak flow meter) and medications used.
What is an AsthmaTracker?
The AsthmaTracker™ can help your track how well your symptoms respond to your treatment plan. By writing down your symptoms, peak expiratory flow rate and medication use each day, you’ll notice a pattern to your symptoms and develop strategies to stop the symptoms before they can stop you.
What is a peak flow meter?
A peak flow meter is a handheld device that measures the peak expiratory flow rate (PEFR), or how much air you can forcibly push out of your lungs at a particular time.
Asthma Storylines – an app for managing asthma
The free Asthma Storylines app is a self-care tool for managing asthma. Track symptoms, learn more about daily patterns and record topics to discuss with your healthcare team.
Are there other conditions that may look like asthma or complicate asthma?
There are other types of respiratory conditions that are different than asthma. The symptoms, diagnosis and treatment can vary depending upon the condition. Here are some of them.